CompoAtlas

SAFFRASOR

Food supplement declared in France, declaration No 2019-4-81

SAFFRASOR (soriabel) is a food supplement declared in France. Status: retrait du marché annoncé pour le 12 November 2028. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
soriabel
Food business operator placing the product on the market
Soriavie
Status
Retrait du marché annoncé pour le 12 November 2028
Form
Gélule
Daily dose
1 gélules par jour
Directions for use
Adultes : 1 gélule le matin
Not recommended for (according to the manufacturer)
Femmes allaitantes, Femmes enceintes, Sous antidépresseurs
Objectives stated by the manufacturer (these are not authorised claims)
Humeur, Système nerveux

Declaration 294674, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Withania somnifera (L.) DunalRacineAutre extrait sec150 mg
Sedum roseum (L.) Scop.RacineAutre extrait sec125 mg
Crocus sativus L.StigmatesAutre extrait sec30 mg

Other active ingredients

NamePer day
Alpha-cyclodextrinenot declared
Gamma-cyclodextrinenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
NicotinamideNicotinamide (vitamine B3)900 mg54 mg
CyanocobalamineVitamine B12pas d'effet indésirable définidose annulée par le Conseil d'État en 2011
Pyridoxal 5'-phosphateVitamine B612 mg2 mg
CholécalciférolVitamine D100 µg (4,000 UI)5 µg (200 UI)
Gluconate de zincZinc25 mg15 mg

Additives

E460, E470b, E464, E551

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

L'usage chez les femmes enceintes ou allaitantes est déconseillé. En cas de traitement contre la dépression il est conseillé de consulter votre médecin ou pharmacien .

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : soriabel

Enter to analyse, Shift+Enter for a new line